J
John T. Wei
Researcher at University of Michigan
Publications - 395
Citations - 32685
John T. Wei is an academic researcher from University of Michigan. The author has contributed to research in topics: Prostate cancer & Cancer. The author has an hindex of 82, co-authored 385 publications receiving 30140 citations. Previous affiliations of John T. Wei include Johns Hopkins University & United States Department of Veterans Affairs.
Papers
More filters
Journal ArticleDOI
Prospective assessment of patient reported urinary continence after radical prostatectomy.
TL;DR: The nerve sparing technique of radical prostatectomy was associated with improved recovery of urinary continence in an age dependent manner, whereas bladder neck preservation was not beneficial.
Journal ArticleDOI
Identifying risk factors for potentially avoidable complications following radical cystectomy.
Brent K. Hollenbeck,David C. Miller,David A. Taub,Rodney L. Dunn,Shukri F. Khuri,William G. Henderson,James E. Montie,Willie Underwood,John T. Wei +8 more
TL;DR: Measurable patient specific risk factors and perioperative processes associated with postoperative morbidity following cystectomy are delineated which allows for improved risk stratification, patient counseling, and the development of novel processes that may incrementally reduce risk and improve outcomes.
Journal ArticleDOI
Prostate cancer early detection. Clinical practice guidelines in oncology
Mark H. Kawachi,Robert R. Bahnson,Michael J. Barry,J. Erik Busby,Peter R. Carroll,H. Ballentine Carter,William J. Catalona,Michael S. Cookson,Jonathan I. Epstein,Ruth B. Etzioni,Veda N. Giri,George P. Hemstreet,Richard J. Howe,Paul H. Lange,Hans Lilja,Kevin R. Loughlin,James L. Mohler,Judd W. Moul,Robert B. Nadler,Stephen G. Patterson,Joseph C. Presti,Antoinette M. Stroup,Robert W. Wake,John T. Wei +23 more
TL;DR: The NCCN guidelines incorporate many new validated findings in addition to the DRE and PSA test that will achieve the goal of assisting patients and clinicians who are choosing a program of early detection for prostate cancer to make decisions regarding the need for prostate biopsy.
Journal ArticleDOI
Can Urinary PCA3 Supplement PSA in the Early Detection of Prostate Cancer
John T. Wei,Ziding Feng,Alan W. Partin,Elissa C. Brown,Ian M. Thompson,Lori J. Sokoll,Daniel W. Chan,Yair Lotan,Adam S. Kibel,J. Erik Busby,Mohamed Bidair,Daniel W. Lin,Samir S. Taneja,Rosalia Viterbo,Aron Y. Joon,Jackie Dahlgren,Jacob Kagan,Sudhir Srivastava,Martin G. Sanda +18 more
TL;DR: Data independently support the role of PCA3 in reducing the burden of prostate biopsies among men undergoing a repeat prostate biopsy and improved the stratification of cancer and of high-grade cancer.
Journal ArticleDOI
Incidence of Initial Local Therapy Among Men With Lower-Risk Prostate Cancer in the United States
TL;DR: These data quantify a target population for whom greater use of expectant approaches may reduce overtreatment and improve the quality of localized prostate cancer care.